For: | Santos PB, Patel H, Henrique R, Félix A. Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer? World J Clin Oncol 2020; 11(2): 43-52 [PMID: 32133274 DOI: 10.5306/wjco.v11.i2.43] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v11/i2/43.htm |
Number | Citing Articles |
1 |
Teow J. Phua. The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective. Medicines 2021; 8(6): 30 doi: 10.3390/medicines8060030
|
2 |
Melanie Dzulko, Miriam Pons, Andreas Henke, Günter Schneider, Oliver H. Krämer. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188453 doi: 10.1016/j.bbcan.2020.188453
|
3 |
Tanggang Deng, Yugang Xiao, Yi Dai, Lin Xie, Xiong Li. Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.743376
|
4 |
Mojtaba Yousefi, Niloofar Eshaghian, Neda Heidarzadeh-Esfahani, Gholamreza Askari, Hamid Rasekhi, Omid Sadeghi. Dietary intake and biomarkers of linoleic acid and risk of prostate cancer in men: A systematic review and dose-response meta-analysis of prospective cohort studies. Critical Reviews in Food Science and Nutrition 2024; 64(24): 8553 doi: 10.1080/10408398.2023.2200840
|
5 |
Terrance J. Haanen, Caitlin M. O'Connor, Goutham Narla. Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules. Journal of Biological Chemistry 2022; 298(12): 102656 doi: 10.1016/j.jbc.2022.102656
|
6 |
Fernando Pereira Beserra, Lucas Fernando Sérgio Gushiken, Maria Fernanda Hussni, Victor Pena Ribeiro, Flávia Bonamin, Christopher John Jackson, Cláudia Helena Pellizzon, Jairo Kenupp Bastos. Artepillin C as an outstanding phenolic compound of Brazilian green propolis for disease treatment: A review on pharmacological aspects. Phytotherapy Research 2021; 35(5): 2274 doi: 10.1002/ptr.6875
|
7 |
Marisa Shiina, Yutaka Hashimoto, Priyanka Kulkarni, Pritha Dasgupta, Varahram Shahryari, Soichiro Yamamura, Yuichiro Tanaka, Rajvir Dahiya. Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08723-6
|
8 |
Aniekan E. Owen, Ernest C. Agwamba, Mathias E. Gideon, Kelechi Chukwuemeka, Emmanuel U. Ejiofor, Innocent Benjamin, Eze F. Ahukwe, Festus O. Ogungbemiro, Kube T. Maxwell, Amanda-Lee E. Manicum, Hitler Louis. Molecular structure, spectroscopy, molecular docking, and molecular dynamic studies of tetrahydroneoprzewaquinone as potent cervical cancer agent. Zeitschrift für Physikalische Chemie 2024; 238(2): 363 doi: 10.1515/zpch-2023-0330
|
9 |
Radek Kucera, Ladislav Pecen, Ondrej Topolcan, Anshu Raj Dahal, Vincenzo Costigliola, Frank A. Giordano, Olga Golubnitschaja. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA Journal 2020; 11(3): 399 doi: 10.1007/s13167-020-00214-1
|
10 |
Francisco das Chagas Pereira de Andrade, Anderson Nogueira Mendes. Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73203-z
|